BOOSTING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY PROVIDERS AND RAS ASSAYS

inside the speedily evolving subject of oncology exploration, accurate and effective mutation screening is very important for acquiring qualified therapies. The KRAS products and services Platform performs a pivotal position in this landscape by presenting complete alternatives for KRAS mutation profiling and Investigation. KRAS mutations, present